News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) and Bristol-Myers Squibb Company Wins $442 Million Award Against Apotex Corp. Over Plavix Patent
October 20, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi-Aventis SA won a $442 million judgment against Apotex Inc. over the patent for the blood thinner Plavix, the world’s second-biggest selling drug.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
April 30, 2026
·
2 min read
·
Heather McKenzie
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
·
3 min read
·
Tristan Manalac